A prospective study of infliximab withdrawal after 12 months of treatment in patients with Crohn's disease: how will NICE guidance affect patient care?
Laura Blackmore and Adam Harris
DOI: https://doi.org/10.7861/clinmedicine.12-3-235
Clin Med June 2012 Laura Blackmore
Department of Gastroenterology, The Tunbridge Wells Hospital
Roles: Specialist registrar in gastroenterology
Adam Harris
Department of Gastroenterology, The Tunbridge Wells Hospital
Roles: Consultant gastroenterologist
Article Information
vol. 12 no. 3 235-238
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online June 1, 2012.
Copyright & Usage:
© 2012 Royal College of Physicians
Author Information
- Laura Blackmore, Specialist registrar in gastroenterology⇓ and
- Adam Harris, Consultant gastroenterologist
- Address for correspondence: Dr L Blackmore, Department of Gastroenterology, The Tunbridge Wells Hospital, Tonbridge Road, Pembury, Tunbridge Wells, Kent TN2 4QJ; Email: laura.blackmore{at}nhs.net
Article usage
Article Tools
Infliximab withdrawal after 12 months as treatment for Crohn's disease
Laura Blackmore, Adam Harris
Clinical Medicine Jun 2012, 12 (3) 235-238; DOI: 10.7861/clinmedicine.12-3-235
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.